 Connection
Brian Kavanagh to Neoplasms
This is a "connection" page, showing publications Brian Kavanagh has written about Neoplasms.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
2.369 |
|
|
|
-
Kavanagh BD. The Economics of Using Locally Ablative Therapy in Oligometastatic Cancer. Semin Radiat Oncol. 2021 07; 31(3):250-252.
Score: 0.293
-
Kavanagh BD. From the Guest Editor: New Lenses, New Visions for Radiotherapy in the Molecular-Genetic-Immunomodulator Era of Oncology. Cancer J. 2016 Jul-Aug; 22(4):245-6.
Score: 0.207
-
Rusthoven CG, Kavanagh BD. Considerations for observational research: in regard to Jagsi et al. Int J Radiat Oncol Biol Phys. 2015 Mar 01; 91(3):679-80.
Score: 0.188
-
Kavanagh BD, Haffty BG, Tepper JE. Radiation oncology: a snapshot in time, 2014. J Clin Oncol. 2014 Sep 10; 32(26):2825-6.
Score: 0.182
-
Kavanagh BD, Miften M, Rabinovitch RA. Advances in treatment techniques: stereotactic body radiation therapy and the spread of hypofractionation. Cancer J. 2011 May-Jun; 17(3):177-81.
Score: 0.145
-
Kavanagh B. Clinical experience shows that catastrophic late effects associated with ablative fractionation can be avoided by technological innovation. Semin Radiat Oncol. 2008 Oct; 18(4):223-8.
Score: 0.121
-
Kavanagh BD, Kelly K, Kane M. The promise of stereotactic body radiation therapy in a new era of oncology. Front Radiat Ther Oncol. 2007; 40:340-351.
Score: 0.107
-
Kavanagh BD, Raben D. Toward a unified target theory in oncology. Future Oncol. 2006 Aug; 2(4):435-6.
Score: 0.104
-
Kavanagh BD, Timmerman RD. Stereotactic radiosurgery and stereotactic body radiation therapy: an overview of technical considerations and clinical applications. Hematol Oncol Clin North Am. 2006 Feb; 20(1):87-95.
Score: 0.101
-
Kavanagh BD. The emperor's new isodose curves. Med Phys. 2003 Sep; 30(9):2559-60.
Score: 0.085
-
Kavanagh BD, Secomb TW, Hsu R, Lin PS, Venitz J, Dewhirst MW. A theoretical model for the effects of reduced hemoglobin-oxygen affinity on tumor oxygenation. Int J Radiat Oncol Biol Phys. 2002 May 01; 53(1):172-9.
Score: 0.078
-
Grimm J, Marks LB, Jackson A, Kavanagh BD, Xue J, Yorke E. High Dose per Fraction, Hypofractionated Treatment Effects in the Clinic (HyTEC): An Overview. Int J Radiat Oncol Biol Phys. 2021 05 01; 110(1):1-10.
Score: 0.072
-
Kavanagh BD, Khandelwal SR, Schmidt-Ullrich RK, Roberts JD, Shaw EG, Pearlman AD, Venitz J, Dusenbery KE, Abraham DJ, Gerber MJ. A phase I study of RSR13, a radiation-enhancing hemoglobin modifier: tolerance of repeated intravenous doses and correlation of pharmacokinetics with pharmacodynamics. Int J Radiat Oncol Biol Phys. 2001 Mar 15; 49(4):1133-9.
Score: 0.072
-
Cardinale RM, Kavanagh BD. Conformal radiotherapy: what is it and why does it matter? Surg Oncol Clin N Am. 2000 Jul; 9(3):415-34, vii.
Score: 0.068
-
Amini A, Yeh N, Jones BL, Bedrick E, Vinogradskiy Y, Rusthoven CG, Amini A, Purcell WT, Karam SD, Kavanagh BD, Guntupalli SR, Fisher CM. Perioperative Mortality in Nonelderly Adult Patients With Cancer: A Population-based Study Evaluating Health Care Disparities in the United States According to Insurance Status. Am J Clin Oncol. 2018 05; 41(5):476-484.
Score: 0.059
-
Jaffee EM, Dang CV, Agus DB, Alexander BM, Anderson KC, Ashworth A, Barker AD, Bastani R, Bhatia S, Bluestone JA, Brawley O, Butte AJ, Coit DG, Davidson NE, Davis M, DePinho RA, Diasio RB, Draetta G, Frazier AL, Futreal A, Gambhir SS, Ganz PA, Garraway L, Gerson S, Gupta S, Heath J, Hoffman RI, Hudis C, Hughes-Halbert C, Ibrahim R, Jadvar H, Kavanagh B, Kittles R, Le QT, Lippman SM, Mankoff D, Mardis ER, Mayer DK, McMasters K, Meropol NJ, Mitchell B, Naredi P, Ornish D, Pawlik TM, Peppercorn J, Pomper MG, Raghavan D, Ritchie C, Schwarz SW, Sullivan R, Wahl R, Wolchok JD, Wong SL, Yung A. Future cancer research priorities in the USA: a Lancet Oncology Commission. Lancet Oncol. 2017 11; 18(11):e653-e706.
Score: 0.057
-
Chen AB, Li L, Cronin AM, Brooks GA, Kavanagh BD, Schrag D. Estimating Costs of Care Attributable to Cancer: Does the Choice of Comparison Group Matter? Health Serv Res. 2018 08; 53 Suppl 1:3227-3244.
Score: 0.056
-
Amini A, Jones BL, Yeh N, Guntupalli SR, Kavanagh BD, Karam SD, Fisher CM. Disparities in disease presentation in the four screenable cancers according to health insurance status. Public Health. 2016 Sep; 138:50-6.
Score: 0.051
-
Chetty IJ, Martel MK, Jaffray DA, Benedict SH, Hahn SM, Berbeco R, Deye J, Jeraj R, Kavanagh B, Krishnan S, Lee N, Low DA, Mankoff D, Marks LB, Ollendorf D, Paganetti H, Ross B, Siochi RA, Timmerman RD, Wong JW. Technology for Innovation in Radiation Oncology. Int J Radiat Oncol Biol Phys. 2015 Nov 01; 93(3):485-92.
Score: 0.048
-
Westerly DC, Schefter TE, Kavanagh BD, Chao E, Lucas D, Flynn RT, Miften M. High-dose MVCT image guidance for stereotactic body radiation therapy. Med Phys. 2012 Aug; 39(8):4812-9.
Score: 0.039
-
Diot Q, Kavanagh B, Timmerman R, Miften M. Biological-based optimization and volumetric modulated arc therapy delivery for stereotactic body radiation therapy. Med Phys. 2012 Jan; 39(1):237-45.
Score: 0.038
-
Zhang L, Kavanagh BD, Thorburn AM, Camidge DR. Preclinical and clinical estimates of the basal apoptotic rate of a cancer predict the amount of apoptosis induced by subsequent proapoptotic stimuli. Clin Cancer Res. 2010 Sep 01; 16(17):4478-89.
Score: 0.034
-
Hartford AC, Palisca MG, Eichler TJ, Beyer DC, Devineni VR, Ibbott GS, Kavanagh B, Kent JS, Rosenthal SA, Schultz CJ, Tripuraneni P, Gaspar LE. American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) Practice Guidelines for Intensity-Modulated Radiation Therapy (IMRT). Int J Radiat Oncol Biol Phys. 2009 Jan 01; 73(1):9-14.
Score: 0.031
-
Solberg TD, Kavanagh BD, Medin PM. Stereotactic body radiation therapy: a new paradigm in radiotherapy management of cancer. J Am Coll Radiol. 2008 May; 5(5):673-7.
Score: 0.029
-
Newman F, Asadi-Zeydabadi M, Durairaj VD, Ding M, Stuhr K, Kavanagh B. Visual sensations during megavoltage radiotherapy to the orbit attributable to Cherenkov radiation. Med Phys. 2008 Jan; 35(1):77-80.
Score: 0.029
-
Timmerman RD, Kavanagh BD, Cho LC, Papiez L, Xing L. Stereotactic body radiation therapy in multiple organ sites. J Clin Oncol. 2007 Mar 10; 25(8):947-52.
Score: 0.027
-
Timmerman RD, Kavanagh BD. Stereotactic body radiation therapy. Curr Probl Cancer. 2005 May-Jun; 29(3):120-57.
Score: 0.024
-
Song DY, Kavanagh BD, Benedict SH, Schefter T. Stereotactic body radiation therapy. Rationale, techniques, applications, and optimization. Oncology (Williston Park). 2004 Oct; 18(11):1419-30; discussion 1430, 1432, 1435-6.
Score: 0.023
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|